Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
Reversible opening of the blood-brain barrier by anti-bacterial antibodiesE I Tuomanen, S M Prasad, J S George, et al.Research in Veterinary Science|April 17, 2013
Culture phenotypes and molecular characterization of Mycobacterium avium subsp. paratuberculosis isolates from small ruminantsZ Dimareli-Malli, K Mazaraki, K Stevenson, et al.Vaccine|October 31, 1998
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccineP C Fusco, F Michon, M Laude-Sharp, et al.The Journal of Infectious Diseases|June 1, 1997
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutininE Leininger, S Bowen, G Renauld-Mongénie, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 19, 2005
Analysis of protein fragmentation inhibition by an MMP-inhibitor in an in vivo model of heart failure using automated chromatographyJ Randall Slemmon, Cory L Painter, Sashi Nadanaciva, et al.Infection and Immunity|September 1, 1990
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussisA M Delisse-Gathoye, C Locht, F Jacob, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Bordetella pertussis and chronic cough in adultsN H Birkebaek, M Kristiansen, T Seefeldt, et al.FEMS Microbiology Letters|October 15, 1995
Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivityJ F Porter, K Connor, A van der Zee, et al.Leukemia|November 1, 1995
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemiaJ Jurlander, P de Nully Brown, P S Skov, et al.Vaccine|October 21, 1998
Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier proteinF Michon, P C Fusco, C A Minetti, et al.Pageof 15